Jefferies Cuts Price Target on Adeptus Health (ADPT) Following 2Q Report; Reiterates Buy
Tweet Send to a Friend
Jefferies maintained a Buy rating on Adeptus Health (NYSE: ADPT), and cut the price target to $100.00 (from $113.00), following ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
